Bingfeng Lu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- RNA modifications and cancer
- RNA Research and Splicing
- Circular RNAs in diseases
- RNA and protein synthesis mechanisms
- Extracellular vesicles in disease
Papers in
-
- RNA modifications and cancer 6
- RNA Research and Splicing 2
- DNA Repair Mechanisms 1
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 2
- Cancer Genomics and Diagnostics 1
- Co-authors
- Yang Zhao (8 shared papers)Yuping Du (2 shared papers)Zhenghao Huang (1 shared paper)Wu Wu (4 shared papers)Xi Chen (4 shared papers)Shuo Chen (3 shared papers)Qianhui Li (4 shared papers)Xin Liu (2 shared papers)
- Journals
- Cell Death Discovery (2 papers)Journal of Experimental & Clinical Cancer Research (1 paper)iScience (1 paper)Molecular Carcinogenesis (1 paper)Cellular and Molecular Life Sciences (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Bingfeng Lu
11 papers receiving 265 citations
Bingfeng Lu's Hit Papers
Peers
Comparison fields: 5 of 44
- Cancer Research 140
- Molecular Biology 193
- Reproductive Medicine 12
- Obstetrics and Gynecology 8
- Aging 2
Countries citing papers authored by Bingfeng Lu
This map shows the geographic impact of Bingfeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingfeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingfeng Lu more than expected).
Fields of papers citing papers by Bingfeng Lu
This network shows the impact of papers produced by Bingfeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingfeng Lu. The network helps show where Bingfeng Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bingfeng Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 130 | |
| 2 | 2022 | 31 | |
| 3 | Lactate accumulation induces H4K12la to activate super-enhancer-driven RAD23A expression and promote niraparib resistance in ovarian cancer Hit paper breakdown → | 2025 | 28 |
| 4 | 2023 | 18 | |
| 5 | 2022 | 17 | |
| 6 | 2023 | 12 | |
| 7 | 2021 | 10 | |
| 8 | 2022 | 10 | |
| 9 | 2021 | 7 | |
| 10 | 2024 | 1 | |
| 11 | 2014 | 1 | |
| 12 | 2019 | 1 | |
| 13 | 2025 | 0 |
About Bingfeng Lu
Bingfeng Lu is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Biomaterials, having authored 13 papers that have together received 266 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (2 papers), RNA Research and Splicing (2 papers), Sarcoma Diagnosis and Treatment (1 paper), DNA Repair Mechanisms (1 paper), Nanoplatforms for cancer theranostics (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Cancer Research (140 citations), Molecular Biology (193 citations), Reproductive Medicine (12 citations), Obstetrics and Gynecology (8 citations) and Aging (2 citations). Bingfeng Lu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yang Zhao, Yuping Du, Zhenghao Huang, Wu Wu, Xi Chen, Shuo Chen, Qianhui Li, Xin Liu, Xue Guan and Shuo Chen. Their work appears in journals such as Cell Death Discovery, Journal of Experimental & Clinical Cancer Research, iScience, Molecular Carcinogenesis and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.